Trials / Completed
CompletedNCT06534632
Oral Care With Colostrum for Preventing Late-onset Sepsis in Preterm Infants
Does Oral Care With Mother's Colostrum Reduce the Risk of Late-Onset Sepsis in Preterm Infants
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- General Organization for Teaching Hospitals and Institutes · Academic / Other
- Sex
- All
- Age
- 1 Hour – 24 Hours
- Healthy volunteers
- Not accepted
Summary
This clinical trial aimed to evaluate the efficacy of the oral mother's colostrum administration for preventing late-onset sepsis in premature neonates during their stay in the neonatal intensive care unit. The investigators hypothesized that premature infants who receive oral mother's colostrum would have a lower incidence of late-onset sepsis and better hospital outcomes, compared to infants who receive a placebo.
Detailed description
The study was a randomized clinical trial, performed on very-low-birthweight premature newborns admitted to the neonatal intensive care unit of Mataria Teaching Hospital after considering exclusion criteria. The enrolled newborns were randomly subdivided into two groups (1:1). The colostrum group received their mother's colostrum, and the placebo group received placebo (sterile water) using a standardized protocol. The newborns received 0.2 mL of the colostrum or placebo orally using a swab directed backward into the oropharynx (0.1 mL on either side of the oral cavity), starting during the first 24 hours of life and lasting for 5 days. Vital signs were carefully monitored throughout the procedure. Dosing was provided every 6 hours during the study period. All infants underwent follow-up from birth until discharge or death whichever came first. Neonates were evaluated for occurrence of late-onset sepsis, death, and other clinical outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Mother's colostrum | Oropharyngeal administration of mother's colostrum |
| OTHER | Placebo | Oropharyngeal administration of sterile water |
Timeline
- Start date
- 2022-11-01
- Primary completion
- 2023-10-30
- Completion
- 2023-11-01
- First posted
- 2024-08-02
- Last updated
- 2024-08-05
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06534632. Inclusion in this directory is not an endorsement.